U.S. Packaging Stock News

NYSE:GEL
NYSE:GELOil and Gas

Assessing Genesis Energy (GEL) Valuation After Strong Q4 Earnings And Distribution Increase

Genesis Energy (GEL) has come back into focus after reporting stronger than expected fourth quarter earnings. The results were supported by offshore pipeline transportation growth, better margins, and a 9.1% increase in its quarterly common unit distribution. See our latest analysis for Genesis Energy. At a share price of $17.66, Genesis Energy has paired its stronger than expected fourth quarter earnings and higher distribution with positive momentum, including a 15.5% 90 day share price...
NYSE:PRLB
NYSE:PRLBMachinery

How Proto Labs’ New AI-Powered ProDesk Platform At Proto Labs (PRLB) Has Changed Its Investment Story

Earlier this month, Proto Labs launched ProDesk, an AI-powered online platform that gives product development and procurement teams real-time quoting, design-for-manufacturability analysis across injection molding, CNC machining and 3D printing, and a collaborative dashboard for managing orders and production parts. A key feature is ProDesk’s AI-driven feedback and shared Production Catalog, which could make Proto Labs more embedded in customers’ day-to-day product development...
NYSE:WTTR
NYSE:WTTREnergy Services

Is Select Water Solutions (WTTR) Pricing Reflect Recent Energy Sector Water Projects Accurately

If you are looking at Select Water Solutions and wondering whether the current price reflects its true worth, this article will walk through what the numbers are actually saying about the stock. The share price last closed at US$13.26, with returns of 4.2% over 7 days, 12.2% over 30 days, 19.6% year to date, 1.8% over 1 year, 79.7% over 3 years, and 120.8% over 5 years. This gives useful context before comparing that price to estimates of value. Recent news around Select Water Solutions has...
NYSE:SCHW
NYSE:SCHWCapital Markets

Is Charles Schwab (SCHW) Attractively Priced After Recent Share Price Weakness

If you are wondering whether Charles Schwab is reasonably priced at its current level, this article walks through the numbers so you can judge the value for yourself. The stock last closed at US$93.08, with a 7 day return of 6.2% decline, a 30 day return of 10.3% decline, a year to date return of 8.4% decline, and a 1 year return of 15.6%, 3 year return of 21.7% and 5 year return of 58.6%. Recent headlines around Charles Schwab have focused on its role as a major US brokerage and bank, as...
NasdaqGS:IPGP
NasdaqGS:IPGPElectronic

Is It Too Late To Consider IPG Photonics (IPGP) After Its 110% One Year Surge?

If you are wondering whether IPG Photonics at around US$134.86 still offers value after a strong run, this article walks through what the current price might be implying. The stock has logged returns of 21.8% over the past week, 65.0% over 30 days, 80.2% year to date and 110.8% over 1 year, while the 3 year return is 6.9% and the 5 year return is a 41.1% decline. Recent attention on IPG Photonics has centered on its position in high power fiber lasers and its role as a supplier to industrial...
BATS:CBOE
BATS:CBOECapital Markets

Assessing Cboe Global Markets (CBOE) Valuation After Earnings Beat And Expanded Russell 2000 Options Trading

Cboe Global Markets (CBOE) is back in focus after reporting fourth quarter and full year 2025 results that topped analyst expectations and after rolling out nearly 24 hour trading for Russell 2000 index options. See our latest analysis for Cboe Global Markets. The recent 1-day share price return of 3.30% takes Cboe Global Markets to US$284.20. It now sits on an 11.76% 90-day share price return alongside a 5-year total shareholder return of 212.64%. This points to momentum that investors...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Assessing Astronics (ATRO) Valuation After Strong 1 Year And 90 Day Share Price Returns

Why Astronics Is On Investors’ Radar Today Astronics (ATRO) is drawing attention after recent price moves, with the stock last closing at US$76.97 and showing strong returns over the past year and past 3 months. See our latest analysis for Astronics. The recent 90 day share price return of 55.95% and very strong 1 year total shareholder return of 307.46% suggest momentum has been building, with shorter term moves reinforcing a much longer rebound story for Astronics. If Astronics’ move has...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

CFO Retirement And Interim Successor Put Focus On MPWR Valuation And Margins

Monolithic Power Systems (NasdaqGS:MPWR) announced the retirement of Chief Financial Officer and Executive Vice President Bernie Blegen after a decade in executive roles. Long-time Corporate Controller Rob Dean has been promoted to interim CFO, marking an internal succession within the finance team. The leadership change highlights a transition at the top of the company’s financial function while the board considers longer term plans for the role. Monolithic Power Systems focuses on analog...
NYSE:CNP
NYSE:CNPIntegrated Utilities

A Look At CenterPoint Energy’s Valuation As Grid Upgrades And Q4 2025 Earnings Come Into Focus

CenterPoint Energy (CNP) is in focus as it prepares to report fourth quarter 2025 results on February 19, alongside recent grid upgrades and the launch of its Community Progress Tracker in Greater Houston. See our latest analysis for CenterPoint Energy. Those grid upgrades and the new Community Progress Tracker arrive at a time when momentum in CenterPoint Energy’s share price has been building, with a 30 day share price return of 7.40% and a 1 year total shareholder return of 29.19% from a...
NYSE:PWR
NYSE:PWRConstruction

Is It Too Late To Consider Quanta Services (PWR) After Its Strong Multi‑Year Rally?

If you are wondering whether Quanta Services at around US$525 a share still offers value, you are not alone. This article is designed to help you assess that question clearly. The stock has recorded returns of 2.8% over the last 7 days, 12.5% over the last 30 days, 19.4% year to date and 82.8% over the past year, with a very large 5 year return that is well over 5x the starting point. This naturally raises questions about what is already priced in. Recent headlines around Quanta Services...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Waystar Integration Of Iodine And AI Recognition Reshape Growth Outlook

Waystar Holding (NasdaqGS:WAY) has rapidly integrated Iodine Software following its acquisition, completing key revenue cycle and clinical intelligence alignment ahead of schedule. The combined platform now reaches a larger hospital client base and is being recognized nationally for its AI driven revenue cycle automation. Waystar was recently named an Inc. Best in Business honoree for AI Implementation, highlighting its role in healthcare revenue cycle automation. Waystar's recent moves...
NYSE:FHI
NYSE:FHICapital Markets

A Look At Federated Hermes (FHI) Valuation As Shares Trade Near Fair Value Estimates

Federated Hermes (FHI) has drawn fresh attention after recent trading left the shares with a reported intrinsic discount of about 13%, prompting investors to reassess the asset manager’s valuation and long term return profile. See our latest analysis for Federated Hermes. Recent trading has been choppy, with the 1 day share price return of Federated Hermes at a 1% decline. However, the 90 day share price return of 14.24% and the 1 year total shareholder return of 46.58% point to building...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Cognex (CGNX) Is Up 32.7% After Earnings Beat, Board Refresh And Completed Buybacks – Has The Bull Case Changed?

Cognex recently reported fourth-quarter 2025 sales of US$252.34 million and full-year sales of US$994.36 million, alongside higher net income and earnings per share, while completing a US$500 million share repurchase program and declaring a quarterly dividend of US$0.085 per share. On top of these capital returns, the Board refreshed its membership by appointing automation and enterprise sales veterans Dr. Sami Atiya and Chris Donato, changes that could influence how Cognex pursues AI-driven...
NYSE:MTN
NYSE:MTNHospitality

Did Oasis’ US$122 Million MTN Buy After Weak Ski Season Just Reframe Vail’s Resilience Story?

In the fourth quarter of 2025, Oasis Management disclosed buying 833,500 Vail Resorts shares, lifting its stake by about US$122.66 million despite season-to-date skier visits falling 20% and related lift, ski school, and dining revenues also declining due to below-average snowfall. This sizable purchase by a professional investor, even after a weak ski season, highlights differing views on Vail Resorts’ longer-term business resilience and earnings power. We’ll now examine how Oasis...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

How Investors May Respond To Interparfums (IPAR) Rising Estimates Amid Expectations Of Lower Earnings

Interparfums, the fragrance maker behind brands such as Kate Spade and Abercrombie & Fitch, recently attracted attention after analysts revised earnings estimates higher for the quarter ended December 2025, even as they anticipated earnings would decline year over year on higher revenue. This shift in expectations, alongside the company’s track record of 14.1% annual revenue growth over the past three years and strong returns on invested capital, has reinforced confidence in its ability to...
NasdaqGS:SVRA
NasdaqGS:SVRABiotechs

A Look At Savara (SVRA) Valuation After Recent FDA Progress And Strengthened Outlook

Why Savara’s recent FDA progress is back in focus Savara (SVRA) is back on investor radars after resubmitting its biologics license application, completing a tech transfer to Fujifilm, and aligning key analytical protocols with the FDA. With an FDA filing decision expected in the near term and management expressing strong confidence in the updated package, the upcoming Guggenheim Securities Emerging Outlook, Biotech Summit presentation on February 11 is drawing extra attention from...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

Is LeMaitre Vascular (LMAT) Pricing Too Rich After Mixed Long Term Returns?

If you are wondering whether LeMaitre Vascular at around US$89.25 is priced fairly or not, this article will walk through what the current valuation actually implies for you as a shareholder or potential investor. The stock shows a mix of recent returns, with gains of 1.4% over the last 7 days, 1.1% over 30 days and 11.3% year to date, but a 10.6% decline over 1 year, alongside longer term returns of 85.6% over 3 years and 98.2% over 5 years. Recent news coverage around LeMaitre Vascular has...
NYSE:DHR
NYSE:DHRLife Sciences

Is Danaher (DHR) Attractive After Recent Share Price Weakness?

If you are wondering whether Danaher at around US$206 per share still offers good value, you are not alone. The answer depends on how you look at its underlying business and valuation. The stock has recently been under pressure, with a 6.1% decline over the last week, a 12.6% decline over the last month and a 10.4% decline year to date, although the 1 year return sits at 1.5%. These moves sit against a backdrop of ongoing interest in large, diversified life sciences and diagnostics...
NYSE:S
NYSE:SSoftware

Is There Now An Opportunity In SentinelOne (S) After A 45% One Year Share Price Fall

If you are wondering whether SentinelOne's current share price reflects its true worth, this article will walk through what the numbers are really saying about the stock. After its last close at US$13.40, SentinelOne's returns sit at a 2.4% decline over 7 days, a 3.6% decline over 30 days, an 8.5% decline year to date, and a 45.0% decline over the past year, with a 12.5% decline over 3 years. Recent coverage of SentinelOne has focused on its position in cybersecurity and how investor...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

The Bull Case For Construction Partners (ROAD) Could Change Following Raised 2026 Guidance And Buybacks - Learn Why

Construction Partners, Inc. recently reported first-quarter 2026 results showing sales of US$809.47 million and net income of US$17.21 million, and it raised full-year fiscal 2026 revenue and net income guidance while also completing a US$22.94 million share repurchase program announced in April 2024. Alongside these financial updates, the company’s participation at the Barclays 43rd Annual Industrial Select Conference in Miami in February 2026 gave management an additional platform to...
NYSE:AB
NYSE:ABCapital Markets

AllianceBernstein Initiatives In Research And Tech Set Against Valuation Concerns

AllianceBernstein Holding (NYSE:AB) has entered a new joint venture with Societe Generale to build out global research capabilities. The firm is expanding further into private alternatives with capital support from EQH. AllianceBernstein has also signed a multi year partnership with SimCorp to upgrade its investment technology and data infrastructure. For investors watching NYSE:AB, these moves sit alongside a recent share price of $41.43 and multi year total returns of 21.9% over 1 year,...
NasdaqCM:ATOM
NasdaqCM:ATOMSemiconductor

A Look At Atomera (ATOM) Valuation After GAA MST Breakthroughs And New OEM Partnership

Atomera (ATOM) is back on investors’ radar after reporting fourth quarter and full year 2025 results that highlight very small current sales, continued losses, and ongoing investment in its Mears Silicon Technology platform. See our latest analysis for Atomera. The latest earnings release and technical updates landed alongside a sharp shift in sentiment, with a 46.17% 1 day share price return and a 142.80% year to date share price return contrasting with a 5 year total shareholder return...
NYSE:STT
NYSE:STTCapital Markets

What State Street (STT)'s New Prime Money Market ETF and Mariner Deal Mean For Shareholders

In February 2026, State Street Corporation announced that Mariner will adopt Charles River’s Wealth Management Solution to support its goal of scaling from more than 2,080 advisors toward 5,000 while centralizing portfolio management, trading, data integration, and advisor workflows. State Street Investment Management also launched the actively managed State Street Prime Money Market ETF (ticker: MMK), a low-cost prime cash vehicle drawing on its cash team’s US$599.55 billion in assets...
NasdaqGS:PPC
NasdaqGS:PPCFood

Assessing Pilgrim's Pride (PPC) Valuation After Earnings Miss And 2026 Expansion Plan

Pilgrim's Pride (PPC) is back in focus after reporting fourth quarter 2025 earnings, with higher sales and softer margins, plus a sizable 2026 capex plan aimed at prepared foods capacity and operational efficiencies. See our latest analysis for Pilgrim's Pride. The latest earnings release and 2026 capex plan come after a period of firm momentum in the shares, with a 30 day share price return of 5.10% and a 90 day share price return of 15.61%. This is the case even though the 1 year total...